|
|
|
Insider
Information: |
Xstelos Corp. |
Relationship: |
10% Owner |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
4,717,666 |
|
Indirect Shares
|
8,033,264 |
|
|
Direct
Value |
$624,147 |
|
|
Indirect Value
|
$182,901 |
|
|
Total
Shares |
12,750,930 |
|
|
Total
Value |
$807,048 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Myrexis Inc |
MYRX |
10% Owner |
|
0 |
2013-02-27 |
7,000,000 |
Premium* |
|
Enzon Pharmaceuticals Inc |
ENZN |
10% Owner |
2020-03-26 |
4,717,666 |
2020-03-26 |
1,033,264 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MYRX |
Myrexis Inc |
10% Owner |
|
2013-02-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
7,000,000 |
|
- |
|
ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
|
2018-07-27 |
4 |
B |
$0.26 |
$29 |
D/D |
112 |
4,130,224 |
2.37 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
|
2018-07-20 |
4 |
B |
$0.26 |
$92 |
D/D |
355 |
4,092,089 |
2.37 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
|
2018-12-04 |
4 |
B |
$0.22 |
$99 |
I/I |
450 |
1,014,950 |
1.42 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
|
2018-06-25 |
4 |
B |
$0.26 |
$130 |
D/D |
500 |
4,010,959 |
2.37 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
|
2018-07-02 |
4 |
B |
$0.26 |
$156 |
D/D |
600 |
4,046,324 |
2.37 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
|
2018-07-11 |
4 |
B |
$0.26 |
$165 |
D/D |
635 |
4,091,734 |
2.37 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
|
2018-06-04 |
4 |
B |
$0.26 |
$260 |
D/D |
1,000 |
3,940,264 |
2.37 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
|
2018-12-06 |
4 |
B |
$0.22 |
$242 |
I/I |
1,100 |
1,016,050 |
1.42 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
|
2018-06-26 |
4 |
B |
$0.26 |
$291 |
D/D |
1,120 |
4,012,079 |
2.37 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
|
2018-06-29 |
4 |
B |
$0.26 |
$338 |
D/D |
1,300 |
4,045,724 |
2.37 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
|
2018-06-05 |
4 |
B |
$0.26 |
$520 |
D/D |
2,000 |
3,942,264 |
2.37 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
|
2019-01-07 |
4 |
B |
$0.26 |
$510 |
D/D |
2,000 |
4,681,666 |
2.37 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
|
2018-11-16 |
4 |
B |
$0.21 |
$525 |
I/I |
2,500 |
917,000 |
1.42 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
|
2018-12-07 |
4 |
B |
$0.22 |
$550 |
I/I |
2,500 |
1,018,550 |
1.42 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
|
2019-01-04 |
4 |
B |
$0.26 |
$638 |
D/D |
2,500 |
4,679,666 |
2.37 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
10% Owner |
|
2020-03-23 |
4 |
B |
$0.14 |
$375 |
I/I |
2,678 |
2,928 |
1.42 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
|
2018-07-10 |
4 |
B |
$0.26 |
$728 |
D/D |
2,800 |
4,091,099 |
2.37 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
|
2018-05-02 |
4 |
B |
$0.26 |
$780 |
D/D |
3,000 |
3,771,064 |
2.37 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
|
2018-08-14 |
4 |
B |
$0.26 |
$936 |
D/D |
3,671 |
4,576,066 |
2.37 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
|
2018-05-17 |
4 |
B |
$0.26 |
$1,040 |
D/D |
4,000 |
3,863,564 |
2.37 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
|
2019-01-03 |
4 |
B |
$0.26 |
$1,148 |
D/D |
4,500 |
4,677,166 |
2.37 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
|
2018-04-13 |
4 |
B |
$0.26 |
$1,222 |
D/D |
4,700 |
3,582,364 |
2.37 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
|
2018-05-22 |
4 |
B |
$0.26 |
$1,430 |
D/D |
5,500 |
3,939,264 |
2.37 |
- |
|
ENZN |
Enzon Pharmaceuticals In... |
See Footnote 1 |
|
2018-07-30 |
4 |
B |
$0.26 |
$2,146 |
D/D |
8,255 |
4,138,479 |
2.37 |
- |
|
55 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|